Stablecoin Development Corp (SDEV) compared with its closest peers (CYPH, LIXT, HRTX, TLPH, RNXT): P/E 0.1 vs industry 17.0. Peer set by Business model: Biotech (Clinical / Commercial-Stage); 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Cypherpunk Technologies Inc. (CYPH) | $67.13M | 16.5 |
| Lixte Biotechnology Holdings, Inc. (LIXT) | $65.21M | -3.1 |
| Heron Therapeutics, Inc. (HRTX) | $64.55M | -10.8 |
| Talphera, Inc. (TLPH) | $62.02M | — |
| RenovoRx, Inc. (RNXT) | $59.31M | — |
| Clene Inc. (CLNN) | $56.15M | -2.2 |
| Context Therapeutics Inc. (CNTX) | $54.75M | -3.9 |
| Xilio Therapeutics, Inc. (XLO) | $52.68M | -0.2 |
| Impact BioMedical Inc. (IBO) | $51.75M | 65.6 |
| TransCode Therapeutics, Inc. (RNAZ) | $50.20M | -0.1 |
| Stock P/E | 0.1 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.0 |
| vs Sector | -99.7% |
| vs Industry | -99.7% |
SDEV overview · SDEV earnings · SDEV financials · SDEV KPIs · SDEV investor relations · SDEV ownership · SDEV filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.